Introduction {#sec1}
============

Techniques for manipulating genes in the germline of experimental mammals provide a powerful means to study the pathophysiology of human disease ([@bib12]). Genes can be altered or introduced by the genetic manipulation of embryonic stem cells (ESCs). ESCs, derived from the inner cell mass of blastocysts, can contribute to all embryonic tissues, including the germ cells of developing mice. "Gene targeting" of a specific genetic locus in ESCs has been a staple in the field of genetic manipulation for the last 20 years. Mutations are introduced through homologous recombination by endogenous mechanisms, by TALENs, or by CRISPR/Cas9 ([@bib3; @bib13; @bib19; @bib20]). Genetically manipulated ESCs are subsequently injected into wild-type blastocysts, which are then surgically transferred to a pseudopregnant surrogate mother to generate chimeric mice that are able to transmit the mutant genetic locus to their progeny. Recent advances allow genetically modified ESCs to be injected immediately into eight-cell embryos, and, when F0 mice are produced, 100% germline transmission efficiency ensues. Either procedure requires that ESCs follow the correct developmental program and contribute to the germline ([@bib11]). However, ESCs often have a low efficiency of germline transmission. It has been shown that mouse ESC (mESC) lines carrying three copies of chromosome 8 (chr8), i.e., Trisomy 8, have a higher growth rate and a diminished efficiency of contribution to the germline as observed in 19/29 karyotyped ESCs ([@bib11]). A comprehensive analysis of mESC clones in Japan revealed only 66% of 540 mESC clones contained normal chromosome counts. When a subset of 88 mESC clones was further analyzed, 40% (35 mESCs) of them contained chromosomal aneuploidy with 34/35 having aneuploidy containing either chr8 and/or chrY ([@bib17]). A recent study, in which 97 mESC lines were analyzed using conventional cytogenetic analysis and fluorescent in situ hybridization (FISH), showed that chromosomal aneuploidy occurs in 32% (31) of the specimens with 30/31 containing either chr8 and/or chrY ([@bib10]). Aneuploidy for all other chromosomes was almost always associated with chr8 and/or chrY (83/85 mESC clones). Only in two cases out of 214 (29+88+97) total analyzed mESC clones, a trisomy was identified (chr11) that did not contain either chr8 and/or chrY. In sum, removal of 39% (83/214) of potentially detrimental mESC clones by karyotype analysis is crucial before injecting modified mESCs into blastocysts.

Unfortunately, existing cytogenetic karyotyping methods are labor intensive, requiring at least 15 fixed metaphase preparations, subsequent DAPI staining, and analysis with an epi-fluorescence microscope equipped with specialized digital imaging software. Conventional karyotyping is expensive (∼\$400/clone) and often needs to be outsourced to specialized core facilities. Therefore, we designed a simple, fast, and cost-effective (∼\$1/clone) SYBR-Green-I-based qPCR procedure to identify common chromosomal aneuploidies found in genetically manipulated mESCs. In contrast to regular PCR, qPCR combines PCR amplification and detection into a single step using detection chemistries such as target-specific hydrolysis probes and SYBR Green I dye, which binds double-stranded DNA and emits fluorescence only when bound. To date, qPCR is the benchmark for gene expression analysis, but recent developments also encourage the use of qPCR for copy number determination ([@bib6]). In this regard, qPCR is currently used for diagnostic copy number profiling of the *SHOX* gene region in idiopathic short stature (ISS) and allied disorders ([@bib5]). In addition, it has been shown to be an elegant tool to accurately screen for correctly targeted mESC clones (using the so-called loss-of-allele assay or LOA) ([@bib7]) and for genotyping of gene-targeted and transgenic mice ([@bib8; @bib15]). These studies show that qPCR can be applied to discriminate 2-fold differences in the copy number of a specific transgene, allowing discrimination between homozygous and hemizygous transgenic animals. We have applied and optimized this method to discriminate among chromosomal aneuploidies, ranging from loss of a chromosome to extra copies of a particular chromosome of interest.

The accumulation of fluorescent signal during the exponential phase of a PCR results in a fast, precise quantification of PCR products and allows for objective data analysis. The quantification cycle or Cq value represents the fractional PCR cycle that is characteristic for the amplification curve (e.g., where increase in fluorescence is maximum) or at which the fluorescence crosses a certain threshold ([@bib6]). Cq value and initial amount of input DNA are inversely related: a sample that contains more copies of template will cross the threshold at an earlier cycle compared to one containing fewer copies of template ([@bib16]). Consequently, the theoretical difference in Cq (dCq) between two and three copies of an autosome is about a half cycle, whereas the dCq between one and two copies is one cycle. With 53 mESC lines (all male), we were able to validate the sensitivity and accuracy of our approach in great detail, which resulted in a quick and user-friendly paradigm to test the quality of any genetically manipulated mESC clone in less than 1 day. We confirmed our approach with the two most common chromosome aneuploidies found in mESCs: chr8 and chrY, and we further validated the approach with rare chr11 and partial chr1 aneuploidies among our collection of cytogenetically karyotyped clones.

Results {#sec2}
=======

Extensive Karyotyping of 141 ESC Clones {#sec2.1}
---------------------------------------

A large karyotyping project in our lab revealed that out of 141 mESC lines analyzed with conventional DAPI-band karyotyping, 48.2% of the clones (68 total) were "normal" and do not contain chromosomal breakage or low mitotic index; 51.8% of the clones (73 in total) had chromosomal abnormalities including Trisomy 8 (24.8%), loss of chrY (9.2%), both Trisomy 8 and 11 (2.1%), both Trisomy 8 and an extra copy of chrY (0.7%), and other structural abnormalities (14.2%). Overall, our data revealed that 38% (53/141) of mESC clones contained either chr8 and/or chrY aneuploidy ([Table S1](#app2){ref-type="sec"} available online) consistent with data reported in the literature ([@bib10; @bib11; @bib17]). Only 1/141 mESC clones (ESC 8) contained a trisomy that did not also contain chr8 and/or chrY (31% of ESC 8 cells contained an extra chr1). The overall rate derived from the three published studies and our study suggests that non-chr8 and/or non-chrY aneuploidies appear at an equal or lower rate than 3/355 mESC clones (0.84%). Two anomalies that cannot be identified by any method other than cytogenetic karyotyping (chromosomal breakage and low mitotic index) occurred in 4/141 ESC clones (2.8%). Thus, chr8 and chrY aneuploidies are by far the most common cytogenetic anomalies identified.

Quantitative Real-Time PCR Using SYBR Green I Dye {#sec2.2}
-------------------------------------------------

We set up a qPCR approach to identify the most common aneuploidies (chr8 and chrY) and the rare aneuploidies (chr1 and chr11) using two chromosomes without aneuploidy (chr7 and chrX), which serve as our references. DNA isolated from 53 mESC lines is utilized in the qPCR validation experiments ([Table 1](#tbl1){ref-type="table"}). We use the SYBR Green I dye as the fluorogenic marker to keep the method simple and easily applicable for any lab. Hydrolysis probes, at considerable costs, may also function; however, our approach requires only one well-designed and characterized primer set per target chromosome and no sequence-specific probe, significantly reducing assay setup. For the qPCR, we designed primers that specifically generate exonic amplicons located on mouse chr1 (*olfr16*), chr7 (*omp*), chr8 (*olfr370*), chr11 (*olfr1*), chrX (*obp1a*), and chrY (*sry*) and extensively validated them in silico and empirically according to the latest Minimum Information for Publication of Quantitative Real-Time PCR Experiments (MIQE) guidelines ([@bib2]) ([Table 2](#tbl2){ref-type="table"}). Intronic region amplicons, with reduced genomic complexity, gave inconsistent results (data not shown) and were avoided. To increase PCR efficiency and accessibility of the genomic DNA, we digested all mESC DNA with restriction endonucleases before qPCR screening, reducing the genomic DNA (gDNA) viscosity. All samples were run in triplicate, and the average Cq value per sample was used in the calculations. The absolute average of the difference between the triplicate Cq values of all our samples was 0.0732 ± 0.0737. If any absolute Cq difference (\|dCq\|) was greater than 0.2206 (i.e., 0.0732 + 2 SDs) between triplicates, then this PCR was repeated.

Data Analysis Using the 2^−ddCq^ Method {#sec2.3}
---------------------------------------

Our assay uses relative quantification to calculate the target chromosome copy number by the so-called comparative Cq method or 2^−ddCq^ method ([@bib14; @bib16]). This method compares the Cq value of one target gene to another internal control or reference gene from a single sample. We chose genes on chr7 (*omp*) and chrX (*obp1a*) as reference genes because no aneuploidy was detected for either in any of our 141 karyotyped male mESCs. For the comparative Cq method to be valid, the amplification efficiency of the target and the reference genes must be approximately equal. The amplification efficiencies of each of the primer sets was determined based upon the generation of standard curves using gDNA dilution series and for all primer sets analyzed the PCR efficiencies ranged between 95% and 120% ([Figure S2](#app2){ref-type="sec"}). For the initial calibration of our data, we used three calibrator mESC lines with previously determined, normal cytogenetic karyotypes, which produced germline animals (ESC 31, 52, and 53). We had numerous germline animals produced from mESCs and chose three to calculate an average normalized relative quantity (NRQ). Theoretically, only one calibrator is required for accurate analysis of the data. In the case that no such lines are readily available in the lab, mESCs with a normal cytogenetic karyotype are commercially available (<http://www.atcc.org/>). After initial screening of mESCs using this qPCR method, additional calibrators can be identified and added to future analyses.

The final NRQ value is presented as the fold change in gene copy number normalized to an endogenous reference gene (*omp* on chr7 or *obp1A* on chrX) and relative to one or more samples of known karyotype, the calibrators ([@bib15]). For example, a cell line with a normal karyotype has a final NRQ that is approximately 1 (including our calibrator), whereas loss of chrY-cells results in a NRQ of approximately 0 (for the *sry* gene) and Trisomy 8 or 11 cells show a NRQ of 1.5 (for *olfr370* or *olfr1*, respectively). We tested our method by calculating the NRQ value for chr8 (*olfr370*), chr11 (*olfr1*), and chrY (*sry*) in 34 ESC lines with known cytogenetic karyotypes and normalized the results against the NRQ value for our reference genes chr7 (*omp*) and chrX *(obp1a)*, see [Experimental Procedures](#sec4){ref-type="sec"}. To obtain the absolute copy number for each of the chromosomes of interest, the following formula ([@bib7]) was applied ([Figures 1](#fig1){ref-type="fig"}, [S1](#app2){ref-type="sec"}A, and S1B):$$\text{Copy}\mspace{9mu}\text{number} = \text{calibrator}\mspace{9mu}\text{copy}\mspace{9mu}\text{number}\mspace{9mu}\text{X}\mspace{9mu}\text{NRQ}{}.$$

The Interchromosomal SD {#sec2.4}
-----------------------

In order for this method to be readily applicable in any lab, we defined a standardized confidence level to assess aneuploidy of any given mESC clone. This cutoff level is mathematically imposed by the relative differences between Cq values, not likely to vary between labs or instruments. A sample is considered to be "normal" (normal chromosomal count) when the NRQ values for chr8, chr11, and chrY are all approximately 1. If any value becomes significantly greater or smaller than 1, then aneuploidy is present. We further defined this divergence away from 1 by determining the likelihood that an mESC clone had significant NRQ values greater or less than 1. An interchromosomal SD (IC SD) was derived by determining the SD between the NRQs of each amplicon for the different chromosomes within each ESC clone (with the NRQ for our reference chromosomes 7 and X being "1"). To identify an acceptable IC SD, we used 11 "normal" mESC lines to calculate a 95% confidence level (or cutoff line) for any mESC clone to be defined as normal. This cutoff line was derived by averaging the IC SD for the 11 normal ESC lines and adding twice its SD. This \[AVG IC SD + 2 × SD (IC SD)\] = 0.0455 + 2 × 0.0226, which equals 0.0906, can be used to assess all mESCs ([Figure 2](#fig2){ref-type="fig"}). We confirmed all previously identified chr8, chr11, and chrY aneuploidies using our screening method ([Figure 1](#fig1){ref-type="fig"}, left of dotted line) and validated the anomalous IC SD ([Figure 2](#fig2){ref-type="fig"}, above dotted line) of their respective ESC clones. A more stringent cutoff would be the \[AVG IC SD + 1 × SD (IC SD)\], which equals 0.0681. All mESC clones that generated germline animals (ESC 19, 31, 52, 53, and 54) show IC SD below this stringent cutoff ([Figure 2](#fig2){ref-type="fig"}, green bars).

We further validated this method using 19 additional mESC lines with unknown cytogenetic karyotypes. We identified 15 normal mESC lines, one loss of chrY (ESC 45) and two Trisomy 8 (ESC 49, 50) ([Figure 1](#fig1){ref-type="fig"}, right of dotted line, and [Figure 2](#fig2){ref-type="fig"}, below dotted line). We confirmed the cytogenetic karyotypes of ESC 48 (normal) and ESC 45 (loss of chrY) using conventional DAPI banding ([Table 1](#tbl1){ref-type="table"}). ESC 40 consistently yielded IC SDs \>0.0906 ([Figure 2](#fig2){ref-type="fig"}) and subsequent cytogenetic karyotyping revealed chromosomal aberrations in 20% of the cells ([Table S1](#app2){ref-type="sec"}).

Detection of Low-Percentage Chromosomal Imbalances {#sec2.5}
--------------------------------------------------

To determine the limits of the aneuploidy detection by our method, we created mixtures between the normal line ESC 31 and the robust Trisomy 8 line ESC 9 or the loss of chrY line ESC 21. The NRQ values were determined for mixtures with 0%, 5%, 10%, 15%, 20%, 40%, 60%, 80%, and 100% loss of chrY or Trisomy 8 ([Figures 3](#fig3){ref-type="fig"}A and 3B). The IC SD values show detectable chromosomal imbalances for 10% mixtures and above for both chr8 and chrY ([Figure 3](#fig3){ref-type="fig"}C). Thus, our data suggest that 10% Trisomy 8 or loss of chrY is the limit of detection in our qPCR assay. However, using our most stringent IC SD cutoff, mESC clones with 5% Trisomy 8 would be discarded.

Discussion {#sec3}
==========

We are able to rapidly identify the common Trisomy 8 and chrY aneuploidies as well as the rare Trisomy 11 and partial Trisomy 1 aneuploidies in mESCs. Conventional cytogenetic karyotyping requires direct inspection of chromosomal images through human visual interpretation. The SYBR Green qPCR-based assay is numerical with fixed confidence levels and not dependent on such subjectivity ([@bib7]). Our method provides a standardized cutoff IC SD of 0.0906 by which all mESC lines can be determined as "normal." This number might vary slightly, but will not exceed 0.1.

Using a set of 141 karyotyped gene-targeted mESC clones, we found that ∼50% (73 clones) contain abnormal cytogenetic karyotypes that might preclude them from usage in blastocyst injections and prevent the production of germline mutations. From this set of 73 clones, 73% (53) contained aneuploidies of which Trisomy 8 was the most frequent (39/53). The chromosome Y (chrY) aneuploidies (14/53, either loss or gain) were the only other consistent chromosomal aneuploidy identified in our study. ChrY aneuploidies generate (male) mESCs unable to contribute to the germline of male chimeric animals and thus progeny cannot be obtained. The germ cells of male chimeras are typically used to autoexcise a selectable marker cassette. Removal of the selectable marker in a mutation is mandatory because it interferes with gene expression of the surrounding genomic locus.

A cumulative analysis of cytogenetic karyotyping from four groups, including ours, reveals that out of 355 mESC clones only 2 (0.5%) contained Trisomy 11 without accompanying aneuploidies ([@bib11; @bib17]). In our study, Trisomy 11 only occurred in the presence of Trisomy 8 (ESC 13, 16, 18). Therefore, screening for Trisomy 11 aneuploidy is redundant. In addition, these findings are consistent with our single ESC clone containing 31% Trisomy 1 cells without accompanying aneuploidies (ESC 8). In order to identify this 31% Trisomy 1 frequency in ESC 8, we had to cytogenetically karyotype 54 cells ([Table S1](#app2){ref-type="sec"}). To confirm these data, we screened for partial Trisomy 1 with primers to *olfr16* (located on chr1, [Table 2](#tbl2){ref-type="table"}) and show a NRQ value of 1.4, which represents an absolute chr1 copy number of 2.8 (data not shown), similar to where the NRQ value would lay for a 30% Trisomy 8 ([Figure 3](#fig3){ref-type="fig"}A). Our method is straightforward, and the Trisomy 1 data show the ease of adding extra primer sets to the analysis if necessary. In addition, the IC SD for ESC 8 including the chr1 analysis was 0.1699, which is greater than our cutoff of 0.0906, and clearly identifies aneuploidy. Importantly, adding the NRQ values for chr1 to the IC SD calculation for the calibrators (ESC 31, ESC 52, and ESC 53) maintained their IC SD values below 0.05 (data not shown).

Using our screening, we were able to confirm the previously determined cytogenetic karyotypes of 34 mESC lines and to further validate our method using 19 additional mESC lines with unknown cytogenetic karyotypes. Our study includes the screening of five mESC lines that produced germline transmission (ESC 19, 31, 52, 53, and 54), all with an IC SD ranging from 0.0268 to 0.0401, well below our determined cutoff value. Consequently, we believe that the smaller an IC SD value, the greater the likelihood of the mESC line being passaged through the germline. Using mixtures of a normal mESC line with mESC lines containing Trisomy 8 or loss of chrY, we show that our method is able to detect chromosomal imbalances as low as 10% aneuploidy. By contrast, standard cytogenetic karyotyping requires analysis of 29--31 cells to detect 10% aneuploidy or 59--73 cells to detect 5% aneuploidy with a 95% confidence level ([@bib9]); far fewer (15--20 cells) are usually analyzed by a standard cytogenetic core facility. In this regard, ESC 24 shows a borderline IC SD of 0.0912, yet the line gave a normal cytogenetic karyotype when 14 cells were analyzed ([Table 1](#tbl1){ref-type="table"}). Based on our method, this clone would be excluded from blastocyst injection because the elevated IC SD may reflect low-percentage aneuploidies.

Many laboratories are exploring reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) used for drug and disease modeling and directed differentiation experiments. It was previously shown that ∼75% of iPSC lines contain aberrant cytogenetic karyotypes ([@bib1; @bib4]). We have tested our method on one mouse iPSC line with results consistent to cytogenetic karyotyping (data not shown). It has not escaped our attention that this qPCR-based method will significantly reduce the number of iPSC lines requiring cytogenetic karyotyping, greatly reducing costs. In addition, it lays the groundwork for assessing the aneuploidy while passaging mouse iPSC lines, not usually done because of the costs involved in karyotyping numerous iPSC cell lines.

A similar qPCR-based method for comprehensive chromosomal aneuploidy screening of human blastocysts has recently been shown to improve the success of in vitro fertilization ([@bib18]). Although these data demonstrate that the qPCR technology is capable of fast and accurate screening of all 24 human chromosomes, the technique is not readily applicable to mouse ESCs or iPSCs. In contrast, our approach is (1) simple: only one carefully designed primer set per chromosome is required, and all primers are available to the scientific community (RTPrimerDB IDs are shown in [Table 2](#tbl2){ref-type="table"}); (2) cost effective: SYBR Green I is used as the fluorescent dye instead of gene-specific hydrolysis probes, which would increase the cost of the screen tremendously; (3) standardized: we provide a cutoff level by which any clone can be assessed; and (4) sensitive: our technique is able to detect slight percentage differences in aneuploidies. Finally, our method has proved to be robust, as the three controls that were included were shown to be true: (1) interrun Cq differences for the same sample are smaller than the average \|dCq\| between triplicates, not requiring interrun calibration and again simplifying data analysis; (2) independent restriction endonuclease digests for the same DNA sample yield similar IC SD values (ESC 12a and b and ESC 31a and b, [Figure 2](#fig2){ref-type="fig"}); and (3) subsequent passages for a given ESC line yield similar NRQ and IC SD values (ESC 49 and 50 and ESC 7 and 9).

In conclusion, our method is fast and extremely inexpensive and will greatly expedite many researchers' work in generating mESC germline transmission. Furthermore, it is of broad interest to every scientist using genetically modified mice because mESC clones that will produce germline animals can be readily identified.

Experimental Procedures {#sec4}
=======================

This study is written according to the Minimum Information for Publication of Quantitative Real-Time PCR Experiments guidelines (MIQE) to ensure its technical qualities and to allow for correct interpretation and repeatability ([@bib2; @bib5]). A MIQE compliance checklist is available in the [Supplemental Information](#app2){ref-type="sec"} ([Table S2](#app2){ref-type="sec"}).

Cytogenetic Karyotyping of Mouse Embryonic Stem Cell Lines {#sec4.1}
----------------------------------------------------------

Subconfluent cultures were treated with 0.05 μg/ml Colcemid (Karyomax, Invitrogen) for 30--40 min before harvesting according to standard cytogenetics procedures. Briefly, cells were trypsinized (0.025% Trypsin: EDTA, EMD Millipore) to a single-cell suspension, pelleted at 180 × *g* for 8 min, and resuspended in warm 0.075M KCl. After 8 min incubation at 37°C, approximately 1/4 volume of 3:1 methanol/glacial acetic acid fixative was added and gently mixed, and the cells were pelleted as before. The cells were then fixed in three changes of fixative. Fixed cell suspensions were stored at −20°C. Fixed metaphase preparations were dropped onto dry slides, and the quality of spreading was assessed by phase microscopy. Slides were then air-dried and aged (at 37°C for several days, or at 60°C for several hours). Aged slides were immersed in 0.08 μg/ml DAPI in 2 × saline sodium citrate for 3 min, rinsed, air-dried, and then mounted in antifade solution (Vectashield, Vector Laboratories) and stored at 4°C. DAPI-stained slides were scanned using a Nikon E800 epi-fluorescence microscope equipped with a digital imaging system (Applied Spectral Imaging). Metaphase images were inverted to resemble conventional G-banding and karyotyped using BandView software (ASI). Where possible, a minimum of 15 metaphases was examined for each sample. All metaphases were fully karyotyped. To avoid confusion, abnormal karyotypes were described according to the International System for Human Cytogenetic Nomenclature (ISCN), rather than the Standardized Genetic Nomenclature for Mice, because the experimental systems are intended to model human disease.

Tissue Culture and Genomic DNA Preparation {#sec4.2}
------------------------------------------

Gene-targeted mESC lines from 13 different electroporations (into E14 parental ESC line, 129ola) grown on a 4 cm^2^ growth area (Gene Targeting Facility, The Rockefeller University) were thawed and plated on 9.6 cm^2^ wells (6-well plate) onto mitotically inactivated mouse embryonic fibroblasts (MEFs) (Millipore) in a standard ESC medium (EmbryoMax Dulbecco's Modified Eagle Medium \[DMEM\], High Glucose, Low Bicarbonate without sodium pyruvate \[EMD Millipore\], supplemented with 15% ESC-approved fetal bovine serum \[FBS, Gibco\], EmbryoMax Nucleosides \[100×\] 1%, EmbryoMax Penicillin-Streptomycin \[100×\] 1%, EmbryoMax Non-Essential Amino Acids \[100×\] 1%, EmbryoMax L-Glutamine Solution \[100×\] 1%, EmbryoMax 2-Mercaptoethanol (100×) 1%, and ESGRO mLIF Medium Supplement 1000, units/ml \[all from EMD Millipore\]). Cells were maintained at 37°C and 5% CO~2~ in a humidified incubator. At 90%--95% confluency, the cells were passaged into a 25 cm^2^ flask (T-25) on MEFs. At 90%--95% confluency, the cells were trypsinized and transferred into a new T-25 flask without MEFs. After 30 min, the medium containing the cells was gently removed and plated into a new flask without MEFs. The MEFs adhere to the flask in about 30 min, whereas the ESCs require longer time to attach and remain in the suspension. Thus, a significant number of MEFs can be removed by this differential adhesion step. The MEFs removal protocol was repeated on the following day to ensure a complete lack of MEFs, which is crucial to the accuracy of the qPCR karyotyping. 30 min posttrypsinization, the medium containing the ESCs was collected into a sterile 15 ml centrifuge tube and spun at 1000 rpm for 5 min. The supernatant was removed, and the pellet was resuspended in 6 ml of lysis buffer (100 ml protocol: 10 mM Tris-HCl \[pH 7.5\] = 0.5 ml of 2 M, 10 mM EDTA = 2 ml of 0.5 M, 10 mM NaCl = 0.2 ml of 5 M, 0.5% \[w/v\] Sarkosyl = 0.5 g N-lauroylsarcosine \[Sigma \#L-9150\]) and 40 μl of proteinase K (200 mg/ml, Fisher Scientific) and incubated overnight at 55°C. The DNA was precipitated by adding 6 ml of isopropanol and gently inverting the tube four to five times. The DNA pellet was resuspended in 400 μl of Tris-EDTA buffer (Fisher Scientific), and the tube was air-dried at 42°C for 1--2 hr. A second 42°C closed-cap incubation was performed overnight. The gDNA concentrations of all samples ranged between 55.44 ng/μl (ESC 37) and 1,897.12 ng/μl (ESC 50) with a median of 316.79 ng/μl and an average 260/280 ratio of 1.90 ± 0.0474. All concentrations are listed in the [Table S6](#mmc5){ref-type="supplementary-material"}. Genomic ESC DNA was digested with EcoRI (New England Biolabs) to remove the viscosity of the sample, which is critical for both the accessibility of the primers and the reproducibility of the Cq values. None of the amplicons contain EcoRI restriction sites. Restriction conditions were the following for a total volume of 100 μl:1.gDNA: 3 μl (∼1 μg)2.EcoRI buffer: 10 μl3.EcoRI: 2 μl4.PCR grade water: 85 μl5.Cut for 3 hr at 37°C (no heat inactivation)

SYBR Green I Real-time ESC genomic DNA PCR {#sec4.3}
------------------------------------------

Six PCR primer pairs were designed with Primer3 Software (<http://bioinfo.ut.ee/primer3-0.4.0/>), in silico validated by OligoAnalyzer 3.1 (<http://www.idtdna.com/analyzer/Applications/OligoAnalyzer/>), and synthesized by Integrated DNA Technologies with standard desalting purification. The BLAST program from the NCBI browser (<http://blast.ncbi.nlm.nih.gov/>) was used for in silico specificity analysis and primer sequences were submitted to the RTPrimerDB (<http://medgen.ugent.be/rtprimerdb/>). Primer IDs are shown in [Table 2](#tbl2){ref-type="table"}). The absence of secondary structures in the region in which the primers anneal was verified using MFOLD (<http://mfold.rna.albany.edu/?q=mfold>). The in silico validation was followed by an extensive empirical validation. The specificity of each amplicon was tested based upon melting curve analysis (single peaks) and gel electrophoresis ([Figure S2](#app2){ref-type="sec"}B). Amplification efficiencies were calculated based upon the generation of standard curves using a 2-fold gDNA dilution series ([Figure S2](#app2){ref-type="sec"}A). The linear dynamic range was five dilutions and standard curve slopes, PCR efficiencies, r^2^ values, linear dynamic range and limit of detection (LOD) for all amplicons analyzed is summarized in [Table 2](#tbl2){ref-type="table"}. The qPCR mixture (10 μl) contained 4.25 μl Lightcycler 480 SYBR Green I Master (Roche Diagnostics), 1.7 μl of each primer (at 10 pM), 0.85 μl of deionized H~2~O, and 1.5 μl of digested genomic ESC DNA (i.e., ±15 ng). qPCRs were set up manually using a Matrix Electronic Multichannel Pipette with 12.5 μl Impact 384 Tips (Thermo Scientific, cat\#7421), and the reactions were carried out in white 384-well plates (E&K Scientific, cat\# 486384) covered with ThermaSeal optical covers (Excel Scientific, cat\# TSS-RTQ-100). All plates were spun down prior to covering to eliminate air bubbles. This step is also critical for the reproducibility of the Cq values. Reaction were run on a Roche Lightcycler 480 using the following cycling conditions: an initial denaturation step at 95°C for 5 min, followed by a 35 cycle amplification step of 95°C for 20 s, 60°C for 15 s, and 72°C for 15 s and a final cooling step at 40°C for 30 s. PCR products were detected in the presence of SYBR Green, and the Cq value for the no template controls was \>30 for all primer sets.

Data analysis {#sec4.4}
-------------

Quantification cycle values were extracted using the Lightcycler 480 software (version 1.5.0 SP4) using the second derivative maximum algorithm. Further data analysis was carried out in Excel (see [Tables S3](#mmc2){ref-type="supplementary-material"}, [S4](#mmc3){ref-type="supplementary-material"} and [S5](#mmc4){ref-type="supplementary-material"}) on the exported data as follows:

To calculate the normalized relative quantities (NRQs or 2-ddCq values) for each sample within each gene of interest:1.Calculate the intertriplicate difference in Cq values (dCq~triplicates~). Samples with \|dCq\|~triplicates~ \>0.2206 should be removed from the analysis and repeated.2.Calculate the average Cq value per sample per gene using the triplicate Cq values.3.Calculate the difference in Cq between the gene of interest (GOI) and the reference gene on chr7, i.e., dCq~(GOI-chr7)~.4.Calculate for each gene the difference between the dCq ~(GOI-chr7)~ of each sample and the dCq ~(GOI-chr7)~ of the chosen calibrator (i.e., ddCq). In case of multiple calibrators, repeat the calculation for each calibrator separately.5.Calculate within each chromosome the 2^−ddCq^ for each sample using the previously obtained ddCq values. This is the NRQ value.6.In case of using multiple calibrators, calculate the mean 2^−ddCq^ value for each sample by averaging all NRQ values obtained using the different calibrators.7.This average NRQ value indicates the fold change in dosage of the GOI as compared to the "normal" calibrator(s).8.Calculate the normalization factor using the NRQ values from chrX (NF~X~). The NF~X~ is obtained by subtracting the NRQ (X) from 1 for each sample within chrX. The data are normalized by adding the NF~X~ to the NRQ of each sample within each gene of interest. This sum will yield a NRQ of 1 for all samples within chrX.9.Repeat steps 3--8 for the other endogenous control chrX and normalize the data using the chr7.10.Calculate the average NRQ for each sample within each GOI using both NRQ values.11.This average NRQ value indicates the fold change in dosage of the GOI as compared to the "normal" calibrator(s) and normalized against two stable chromosomes, i.e., chr7 and chrX (i.e., the normalized relative quantity or NRQ).12.This value may be multiplied by 2 to obtain the absolute copy number for the autosomes or X in case of female ESCs.

To calculate the interchromosomal SD (IC SD):1.Calculate the IC SD per sample by determining the SD between the NRQs for each amplicon of the five different chromosomes within each ESC clone. The NRQ values for chr7 and chrX are 1 and are included in the IC SD calculation.2.When the IC SD is greater than 0.0681, our 67% stringent confidence level (CL), samples may be considered abnormal. If the IC SD is greater than our 95% CL of 0.0906, then samples should be considered abnormal. The corresponding NRQ can subsequently be used to evaluate which of the chromosomes is aneuploid.

Supplemental Information {#app2}
========================
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![Normalized Chromosome Copy Numbers\
The absolute copy number for the autosomes is calculated by multiplying the NRQ values by 2 according to this formula: Copy number = calibrator copy number X NRQ or (2^−ddCq^). A copy number of 2 reflects normal autosome ploidy, and a copy number of 3 reflects trisomy. The absolute copy number of chromosome Y equals the NRQ value. A copy number of 1 reflects normal ploidy, a copy number of 0 reflects loss of chrY, and a copy number of 2 reflects duplication of chrY. A dotted line marks the border between mESCs with previously determined (known) and unknown karyotypes at the time of qPCR analysis. See also [Figure S1](#app2){ref-type="sec"}.](gr1){#fig1}

![Interchromosomal SDs\
The IC SD represents the interchromosomal SD of NRQ values between all chromosomes within an mESC line. The confidence level (CL) of 0.0906 was calculated using 11 known, normal mESC lines and can be used as a standardized cutoff line (shown in black) to assess karyotypes of any cell lines. mESC lines that produced germline animals are highlighted in green, and all show IC SD values even below our stringent cutoff of 0.0681. The IC STDEV refers to the interchromosomal SD or IC SD.](gr2){#fig2}

![Detection of Low-Percentage Chromosomal Imbalances\
Normalized chromosome copy numbers for percentage changes in chromosome 8 (A), chromosome Y (B), and corresponding IC SD values (C). To obtain a gradual decrease in loss of chrY or a gradual increase in chr8, we mixed appropriate volumes of a normal control and calibrator (ESC 31) with a 100% loss of chrY cell line (ESC 21) or a robust 100% Tri8 line (ESC 9), respectively. The IC SD values show detectable chromosomal imbalances for 10% mixtures and above for both chr8 and chrY, reflecting the sensitivity of our method. Blue squares indicate the internal controls, green squares (A and B) or bars (C) indicate dilutions below the limit of detection (and are considered "normal" according to our cutoff level), and red squares (A and B) or bars (C) indicate partial Trisomy 8 (A) or partial Loss of chrY (B) are considered "aneuploidy" according to our cutoff level. The IC STDEV refers to the interchromosomal SD or IC SD.](gr3){#fig3}

###### 

Cytogenetic Karyotypes of Mouse ESC Lines Used for qPCR

  Cell Line                                 ISCN                                    Cell Line   ISCN
  ----------------------------------------- --------------------------------------- ----------- ---------------------
  **Normal**                                **Trisomy 8**                                       
                                                                                                
  ESC 3                                     40,XY \[15\]                            ESC 1       41,XY,+8 \[15\]
  ESC 5                                     40,XY \[14\]                            ESC 2       41,XY,+8 \[15\]
  ESC 19[a](#tblfn1){ref-type="table-fn"}   40,XY \[15\]                            ESC 4       41,XY,+8 \[15\]
  ESC 24                                    40,XY \[14\]                            ESC 7       41,XY,+8 \[15\]
  ESC 25                                    40,XY \[14\]                            ESC 9       41,XY,+8 \[15\]
  ESC 31[a](#tblfn1){ref-type="table-fn"}   40,XY \[12\]                            ESC 20      41,XY,+8 \[14\]
  ESC 32                                    40,XY \[13\]                            ESC 27      41,XY,+8 \[13\]
  ESC 33                                    40,XY \[15\]                            ESC 28      41,XY,+8 \[14\]
  ESC 52[a](#tblfn1){ref-type="table-fn"}   40,XY \[14\]                            ESC 29      41,XY,+8 \[15\]
  ESC 53[a](#tblfn1){ref-type="table-fn"}   40,XY \[15\]                            ESC 30      41,XY,+8 \[15\]
  ESC 54[a](#tblfn1){ref-type="table-fn"}   40,XY \[15\]                            ESC 51      41,XY,+8 \[13\]
                                                                                                
  **31% Trisomy 1**                         **Trisomy 8 and Extra chrY**                        
                                                                                                
  ESC8[b](#tblfn2){ref-type="table-fn"}     See [Table S1](#app2){ref-type="sec"}   ESC12       42,XYY,+8 \[15\]
                                                                                                
  **Loss Of chrY**                          **Trisomy 8 and 11**                                
                                                                                                
  ESC 10                                    39,X,-Y \[15\]                          ESC 13      42,XY,+8,+11 \[14\]
  ESC 14                                    39,X,-Y \[15\]                          ESC 16      42,XY,+8,+11 \[13\]
  ESC 15                                    39,X,-Y \[14\]                          ESC 18      42,XY,+8,+11 \[15\]
  ESC 17                                    38∼39,X,-Y \[16\]                                   
  ESC 21                                    39,X,-Y \[15\]                                      
  ESC 22                                    39,X,-Y \[15\]                                      
  ESC 23                                    39,X,-Y \[14\]                                      

The following lines had unknown cytogenetic karyotypes and were used to validate our qPCR approach: ESC 6, ESC 11, and ESC 34--ESC 50. Karyotypes of lines ESC 40, ESC 45, and ESC 48 were confirmed by DAPI-banded karyotyping after obtaining the qPCR results. Karyotypes were the following: ESC 40, 37∼40,XY\[20\]; ESC 45, 38∼39,X,-Y\[15\]/40,XY\[1\]; ESC48, 39∼40,XY\[15\]. See also [Table S1](#app2){ref-type="sec"}.

These cell lines produced germline animals.

ESC8 is of mixed genetic background and was derived in the lab.

###### 

In Silico and Empirical Evaluation of the qPCR Primer Sets[a](#tblfn4){ref-type="table-fn"}

  Chr                         Location               Gene        Primers (5′-3′)             Amplicon Length (bp)   RTprimerDB ID   Standard Curve                               
  --------------------------- ---------------------- ----------- --------------------------- ---------------------- --------------- ---------------- ----- ------- ------------- ---------------------------------------
  1                           172956826--172956929   *olfr16*    GAGTTCGTCTTCCTGGGATTC       103                    8651            −2.904           120   0.997   0.84--13.5    0.09[b](#tblfn5){ref-type="table-fn"}
  TAATGATGTTGCCAGCCAGA                                                                                                                                                           
  7                           98145342--98145482     *omp*       GCCCACTTGATTCCCTGA          140                    8652            −2.907           120   0.997   0.84--13.5    0.07
  GCATCTGCTGGGTCAGGTCC                                                                                                                                                           
  8                           83541895--83542057     *olfr370*   CACTATGGATGTGCCTCTTTTATCT   162                    8653            −3.137           108   0.999   0.84--13.5    0.08
  TACCCTATGAAGAGCTGATTTGAAG                                                                                                                                                      
  11                          73395777--73395941     *olfr1*     TCTATGCCCTGTTCCTGGTC        164                    8654            −3.439           95    0.996   0.84--13.5    0.02
  CAACTTGGGCATTGTGACAG                                                                                                                                                           
  X                           78085543--78085693     *obp1a*     GGATCAGAATTATGGATCATGTG     150                    8655            −2.994           115   0.994   0.84--13.5    0.15
  GATCATGAGAAGGGGAAGGA                                                                                                                                                           
  Y                           2663266--2663432       *sry*       CTCATCGGAGGGCTAAAGTG        166                    8656            −3.235           103   0.985   0.84--13.50   0.28[c](#tblfn6){ref-type="table-fn"}
  AAGCTTTGCTGGTTTTTGGA                                                                                                                                                           

See also [Figure S2](#app2){ref-type="sec"}.

MIQE guidelines compliant.

A LOD of 0.09 ng refers to about 150 cells when screening for autosomes.

A LOD of 0.28 ng refers to about 1,000 cells when screening for sex chromosomes (XO or XY).
